Oryzon
Founded in 2000 in Barcelona, Spain, Oryzon is a clinical stage biopharmaceutical company. Oryzon has ongoing programs for developing inhibitors against other epigenetic targets. Oryzon is headquartered in Catalonia, Spain.
Last updated on
About Oryzon
Founded
2000Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$54MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
28NAICs Code
541612Location
City
Cornella de LlobregatState
CataloniaCountry
SpainTech Stack (21)
